Aptevo Therapeutics Inc. Other Noncash Income (Expense)
Aptevo Therapeutics Inc. (APVO) reported Other Noncash Income (Expense) of $28.00 thousand for the 6-month period ending 2018-06-30, per its 10-Q filed 2018-08-09.
Discontinued › Cash Flow › Operating Activities
us-gaap:OtherNoncashIncomeExpense · last filed 2018-08-09
- Aptevo Therapeutics Inc. other noncash income (expense) for the quarter ending 2018-06-30 was -$159.00K.
- Aptevo Therapeutics Inc. other noncash income (expense) for the quarter ending 2018-03-31 was $187.00K.
| Period end | Other Noncash Income (Expense) 3 month | Other Noncash Income (Expense) 6 month |
|---|---|---|
| 2018-06-30 | -$159.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-09 | $28.00K 10-Q · filed 2018-08-09 |
| 2018-03-31 | $187.00K 10-Q · filed 2018-05-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Onconetix, Inc. (ONCO) | United States | $0.004B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| HCW Biologics Inc. (HCWB) | United States | $0.004B | -6.15 |
| REVELATION BIOSCIENCES, INC. (REVB) | United States | $0.004B | |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B |